Dr. Billy K. Huh, MD

Dr. Huh practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Huh's NPI, 1760566673, was assigned on October 25, 2006. Dr. Huh graduated from Heersink School of Medicine - Birmingham in 1993. Dr. Huh holds Texas license P6424.

Dr. Huh's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Huh's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Huh practices. Vendor and product names are available with a free account.

Anesthesiology is Dr. Huh's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Huh is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Huh's licenses on file in 12 states: Texas, Florida, Georgia, Arizona, Louisiana, Oklahoma, Tennessee, Washington, Alabama, Mississippi, Hawaii and North Carolina.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Huh treats.

CMS data shows 316 Medicare services from Dr. Huh across 4 procedure codes in 2024, for 204 Medicare patients. Medicare paid $25,256 for them.

CMS counts 204 Medicare patients who saw Dr. Huh in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 70% have arthritis. 16% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Huh's median patient age at 67, with 55% women.

In 2024, Dr. Huh wrote 2,102 Medicare Part D claims for 364 patients. 95% of them were for generic drugs. CMS names the drug for 2,015 of them, across 21 drugs with 11 or more claims each, at $67,874 in total drug cost. In 2023, CMS named 2,471 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Huh for performance year 2024, reported as part of a group. Dr. Huh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Huh as offering telehealth.

Dmand AI links 71 papers to Dr. Huh, published from 2009 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Pain Measurement, Analgesics, Opioid and Analgesics. Dr. Huh has published most often in Pain Manag. Dr. Huh's most frequent co-authors are Saba Javed, MD, Salahadin Abdi, MD and Matthew Chung, MD.

CMS Open Payments shows 82 general payments to Dr. Huh from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abbott Laboratories paid the most, $3,308. It also lists 1 research payment totaling $5 in 2019.

Dmand AI lists 1 award for Dr. Huh.

Dr. Huh graduated from Heersink School of Medicine - Birmingham in 1993.

Dr. Huh is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.